INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF
The invention provides an inactivated varicella zoster virus (VZV), and compositions and vaccines comprising said inactivated VZV, wherein the infectivity of the VZV is undetectable and wherein the inactivated VZV induces an immune response against VZV when administered to a patient. In embodiments...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English Korean |
Published |
09.04.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention provides an inactivated varicella zoster virus (VZV), and compositions and vaccines comprising said inactivated VZV, wherein the infectivity of the VZV is undetectable and wherein the inactivated VZV induces an immune response against VZV when administered to a patient. In embodiments of the compositions described herein, the VZV is inactivated with gamma radiation. The invention also provides a method of preparing an inactivated VZV vaccine, the method comprising gamma irradiating a sample comprising a VZV using from about 5 kGy to about 50 kGy of gamma radiation. Also provided by the invention herein is a method of treatment of or immunization against HZ or other disease associated with the reactivation of VZV, the method comprising administering to a subject a vaccine or pharmaceutical composition comprising a therapeutically effective amount of an inactivated VZV and a pharmaceutically acceptable carrier, wherein the VZV is inactivated by gamma irradiation. |
---|---|
AbstractList | The invention provides an inactivated varicella zoster virus (VZV), and compositions and vaccines comprising said inactivated VZV, wherein the infectivity of the VZV is undetectable and wherein the inactivated VZV induces an immune response against VZV when administered to a patient. In embodiments of the compositions described herein, the VZV is inactivated with gamma radiation. The invention also provides a method of preparing an inactivated VZV vaccine, the method comprising gamma irradiating a sample comprising a VZV using from about 5 kGy to about 50 kGy of gamma radiation. Also provided by the invention herein is a method of treatment of or immunization against HZ or other disease associated with the reactivation of VZV, the method comprising administering to a subject a vaccine or pharmaceutical composition comprising a therapeutically effective amount of an inactivated VZV and a pharmaceutically acceptable carrier, wherein the VZV is inactivated by gamma irradiation. |
Author | KRISS JENNIFER A DEHAVEN JILL KRAH DAVID L YAGODICH MARY BARR COLLEEN M |
Author_xml | – fullname: YAGODICH MARY – fullname: BARR COLLEEN M – fullname: DEHAVEN JILL – fullname: KRISS JENNIFER A – fullname: KRAH DAVID L |
BookMark | eNqNi7sKwjAUQDPo4KP_cMG1Qmyge0huSLAmktx2cClF4iRtof4_dvADnA4cztmzzTiNecfIeanIdZJQQyejU9g0Eh4hEUboXGzTqpVyHlMJNyQbdIJg4B6Dbtcz-BKk19AmTEAWIwZzZNvX8F5y8eOBnQySsuc8T31e5uGZx_zpr7HiF8G5qHldSfFf9QU4GTK2 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | KR20130036062A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_KR20130036062A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:54:20 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Korean |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_KR20130036062A3 |
Notes | Application Number: KR20137002903 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130409&DB=EPODOC&CC=KR&NR=20130036062A |
ParticipantIDs | epo_espacenet_KR20130036062A |
PublicationCentury | 2000 |
PublicationDate | 20130409 |
PublicationDateYYYYMMDD | 2013-04-09 |
PublicationDate_xml | – month: 04 year: 2013 text: 20130409 day: 09 |
PublicationDecade | 2010 |
PublicationYear | 2013 |
RelatedCompanies | MERCK SHARP & DOHME CORP |
RelatedCompanies_xml | – name: MERCK SHARP & DOHME CORP |
Score | 2.8603015 |
Snippet | The invention provides an inactivated varicella zoster virus (VZV), and compositions and vaccines comprising said inactivated VZV, wherein the infectivity of... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
Title | INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130409&DB=EPODOC&locale=&CC=KR&NR=20130036062A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1dT8IwFL1BNOqbosYPNE00e2IRxljggZjRdhkCKynbQnwhbMzEaIDIjH_f2wrKE-lL0yZNe5N7Tj9u7wF4aCEpKPETM6vOmqbdyFKzmSQ1s5E6aT2xkdK0HNAgcPzIfh43xgX42PyF0XlCv3VyRPSoFP0913i9_L_EYjq2cvWYvGHT4skL28xYn44RkPG8YrBOmw8FE9SgtN2TRiB_-xCtq47l7sG-2kirTPs87qh_KcttUvFO4GCI483zUyi8L0pwRDfaayU4HKyfvLG69r7VGYTdQMV8xC6iDYld2aW833fJixjhnpTEXRmNsJlSJaRRIQMe-oKNiPDIUAoW6WiRCnEDRiIEURL6XHLhncO9x0Pqmzi9yZ81Jj25vZb6BRTni3l2CWRay2YWkhKWRFGOzsOjGD6zXpuOk15BeddI17u7b-DY0koQtlltlaGYf35lt8jHeXKnzfgDamiE_A |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bT8IwFD5BNOKbosYLahPNnliEMSY8EDPaLZvsQsq2EF-IGzMxGiAy49_3tILyRPrStEnTnuR8Xy-n5wO46yIpCPETNW9MO6rezjO1k6ZNtZ0ZWSvVkdKkHJAfGE6sP43b4xJ8rP_CyDyh3zI5InpUhv5eSLxe_F9iMRlbubxP37Bp_mhHPaasTscIyHheUVi_Zw1DFlKF0t6AKwH_7UO0bhiauQO7DyI_r9g8JX3xL2WxSSr2IewNcbxZcQSl93kVKnStvVaFfX_15I3VlfctjyFyAxHzkZiINiQxuUstzzPJczjCPSlJXB6PsJlSIaRRJ74VOSEbkdAmQx6yWEaL1IkZMBIjiJLIsbgV2idwa1sRdVSc3uTPGpMB31xL6xTKs_ksPwPy0synGpISllRQjszDIxg-1147hpGdQ23bSBfbu2-g4kS-N_HcYHAJB5pUhdDVRrcG5eLzK79Cbi7Sa2nSH8tYh-k |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=INACTIVATED+VARICELLA+ZOSTER+VIRUS+VACCINES%2C+METHODS+OF+PRODUCTION%2C+AND+USES+THEREOF&rft.inventor=YAGODICH+MARY&rft.inventor=BARR+COLLEEN+M&rft.inventor=DEHAVEN+JILL&rft.inventor=KRISS+JENNIFER+A&rft.inventor=KRAH+DAVID+L&rft.date=2013-04-09&rft.externalDBID=A&rft.externalDocID=KR20130036062A |